Predictors of participation restriction over a 9-year period in adults with myotonic dystrophy type 1

References

• Harper P. Myotonic dystrophy: a multisystemic disorder. In: Harper P, Van Engelen B, Eymard B, editors. Myotonic dystrophy: present management, future therapy. Oxford: Oxford University Press; 2004. p. 3–13.
   Google Scholar
• Mah JK, Korngut L, Fiest KM, et al. A systematic review and meta-analysis on the epidemiology of the muscular dystrophies. Can J Neurol Sci. 2016;43(1):163–177.
   PubMed Web of Science ®Google Scholar
• Theadom A, Rodrigues M, Poke G, et al. A nationwide, population-based prevalence study of genetic muscle disorders. Neuroepidemiology. 2019;52(3–4):128–135.
   PubMed Web of Science ®Google Scholar
• Mathieu J, Prevost C. Epidemiological surveillance of myotonic dystrophy type 1: a 25-year population-based study. Neuromuscul Disord. 2012;22(11):974–979.
   PubMed Web of Science ®Google Scholar
• Laberge AM, Michaud J, Richter A, et al. Population history and its impact on medical genetics in Quebec. Clin Genet. 2005;68(4):287–301.
   PubMed Web of Science ®Google Scholar
• Johnson K, Shelbourne P, Davies J, et al. A new polymorphic probe which defines the region of chromosome 19 containing the myotonic dystrophy locus. Am J Hum Genet. 1990;46(6):1073–1081.
   PubMed Web of Science ®Google Scholar
• Harley HG, Walsh KV, Rundle S, et al. Localisation of the myotonic dystrophy locus to 19q13.2-19q13.3 and its relationship to twelve polymorphic loci on 19q. Hum Genet. 1991;87(1):73–80.
   PubMed Web of Science ®Google Scholar
• Yum K, Wang ET, Kalsotra A. Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes. Curr Opin Genet Dev. 2017;44:30–37.
   PubMed Web of Science ®Google Scholar
• Brisson D, Houde G, St-Pierre J, et al. The pleiotropic expression of the myotonic dystrophy protein kinase gene illustrates the complex relationships between genetic, biological and clinical covariates of male aging. Aging Male. 2002;5(4):223–232.
   PubMedGoogle Scholar
• Campione E, Botta A, Di Prete M, et al. Cutaneous features of myotonic dystrophy types 1 and 2: implication of premature aging and vitamin D homeostasis. Neuromuscul Disord. 2017;27(2):163–169.
   PubMed Web of Science ®Google Scholar
• Mateos-Aierdi AJ, Goicoechea M, Aiastui A, et al. Muscle wasting in myotonic dystrophies: a model of premature aging. Front Aging Neurosci. 2015;7:125–141.
   PubMed Web of Science ®Google Scholar
• Hagerman KA, Howe SJ, Heatwole CR. The myotonic dystrophy experience: a North American cross-sectional study. Muscle Nerve. 2019;59(4):457–464.
   PubMed Web of Science ®Google Scholar
• Heatwole C, Bode R, Johnson N, et al. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology. 2012;79(4):348–357.
   PubMed Web of Science ®Google Scholar
• Minier L, Lignier B, Bouvet C, et al. A review of psychopathology features, personality, and coping in myotonic dystrophy type 1. J Neuromuscul Dis. 2018;5(3):279–294.
   PubMedGoogle Scholar
• De Antonio M, Dogan C, Hamroun D, et al. Unravelling the myotonic dystrophy type 1 clinical spectrum: a systematic registry-based study with implications for disease classification. Rev Neurol (Paris). 2016;172(10):572–580.
   PubMed Web of Science ®Google Scholar
• Okkersen K, Buskes M, Groenewoud J, et al. The cognitive profile of myotonic dystrophy type 1: a systematic review and meta-analysis. Cortex. 2017;95:143–155.
   PubMed Web of Science ®Google Scholar
• Laberge L, Mathieu J, Auclair J, et al. Clinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patients. Eur Neurol. 2013;70(5–6):308–315.
   PubMed Web of Science ®Google Scholar
• Laberge L, Veillette S, Mathieu J, et al. The correlation of CTG repeat length with material and social deprivation in myotonic dystrophy. Clin Genet. 2007;71(1):59–66.
   PubMed Web of Science ®Google Scholar
• Gagnon C, Chouinard MC, Laberge L, et al. Health supervision and anticipatory guidance in adult myotonic dystrophy type 1. Neuromuscul Disord. 2010;20(12):847–851.
   PubMed Web of Science ®Google Scholar
• Laberge L, Prevost C, Perron M, et al. Clinical and genetic knowledge and attitudes of patients with myotonic dystrophy type 1. Public Health Genomics. 2010;13(7–8):424–430.
   PubMed Web of Science ®Google Scholar
• World Health Organization. World report on disability. Malta: WHO Library Cataloguing-in-Publication Data; 2011. p. 325.
   Google Scholar
• Fougeyrollas P. La funambule, le fil et la toile: transformations réciproques du sens du handicap. Collection Sociétés, cultures et santé. Québec: Presses de l'Université Laval; 2010. p. 315.
   Google Scholar
• Fougeyrollas P, Boucher N, Edwards G, et al. The disability creation process model: a comprehensive explanation of disabling situations as a guide to developing policy and service programs. Scand J Disabil Res. 2019;21(1):25–37.
   Web of Science ®Google Scholar
• Levasseur M, Desrosiers J, Noreau L. Is social participation associated with quality of life of older adults with physical disabilities? Disabil Rehabil. 2004;26(20):1206–1213.
   PubMed Web of Science ®Google Scholar
• Bourassa KJ, Memel M, Woolverton C, et al. Social participation predicts cognitive functioning in aging adults over time: comparisons with physical health, depression, and physical activity. Aging Ment Health. 2015;21:1–14.
   Web of Science ®Google Scholar
• Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: a meta-analytic review. PLoS Med. 2010;7(7):e1000316.
   PubMed Web of Science ®Google Scholar
• Raymond K, Levasseur M, Mathieu J, et al. Progressive decline in daily and social activities: a 9-year longitudinal study of participation in myotonic dystrophy type 1. Arch Phys Med Rehabil. 2019;100(9):1629–1639.
   PubMed Web of Science ®Google Scholar
• Ashizawa T, Gagnon C, Groh WJ, et al. Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurol Clin Pract. 2018;8(6):507–520.
   PubMedGoogle Scholar
• Noreau L, Edwards G, Boucher N, et al. Enhancing independent community access and participation: services, technologies and policies. In: Dietz V, Ward N, editors. Handbook on neurorehabilitation. Oxford (UK): Oxford University Press; 2015. p. 339–417.
   Google Scholar
• Cup EH, Pieterse AJ, Knuijt S, et al. Referral of patients with neuromuscular disease to occupational therapy, physical therapy and speech therapy: usual practice versus multidisciplinary advice. Disabil Rehabil. 2007;29(9):717–726.
   PubMed Web of Science ®Google Scholar
• Hilton-Jones D. Myotonic dystrophy—forgotten aspects of an often neglected condition. Curr Opin Neurol. 1997;10(5):399–401.
   PubMed Web of Science ®Google Scholar
• Howe S. Christopher Project Reference Group. Report to the myotonic dystrophy community. Marigold Foundation and the Christopher Project; 2019. Available from: https://www.mda.org/sites/default/files/2019/05/July_Monthly_Report_In_the_News_Christopher_Project_Full_Report.pdf
   Google Scholar
• Holmoy AKT, Johannessen CH, Hope S, et al. Uncovering health and social care needs among myotonic dystrophy patients: utility of the Needs and Provisions Complexity Scale. Acta Neurol Scand. 2019;139(6):526–532.
   PubMed Web of Science ®Google Scholar
• Fougeyrollas P, Noreau L, Beaulieu M, et al. La Mesure des habitudes de vie (MHAVIE 3.1). Lac-St-Charles: Réseau international sur le Processus de production du handicap (RIPPH); 2003.
   Google Scholar
• Gagnon C, Mathieu J, Noreau L. Measurement of participation in myotonic dystrophy: reliability of the LIFE-H. Neuromuscul Disord. 2006;16(4):262–268.
   PubMed Web of Science ®Google Scholar
• Desrosiers J, Noreau L, Robichaud L, et al. Validity of the assessment of life habits in older adults. J Rehabil Med. 2004;36(4):177–182.
   PubMed Web of Science ®Google Scholar
• Hair JF, Black WC, Babin BJ, et al. Chapter 4: multiple regression analysis. Multivariate data analysis (revised). 7th ed. Prentice Hall: Pearson Education Limited; 2014. p. 151–230.
   Google Scholar
• Dogan C, De Antonio M, Hamroun D, et al. Gender as a modifying factor influencing myotonic dystrophy type 1 phenotype severity and mortality: a nationwide multiple databases cross-sectional observational study. PLoS One. 2016;11(2):e0148264.
   PubMed Web of Science ®Google Scholar
• Gagnon C, Mathieu J, Jean S, et al. Predictors of disrupted social participation in myotonic dystrophy type I. Arch Phys Med Rehabil. 2008;89(7):1246–1255.
   PubMed Web of Science ®Google Scholar
• Gagnon C, Mathieu J, Noreau L. Life habits in myotonic dystrophy type 1. J Rehabil Med. 2007;39(7):560–566.
   PubMed Web of Science ®Google Scholar
• Smith AE, McMullen K, Jensen MP, et al. Symptom burden in persons with myotonic and facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil. 2014;93(5):387–395.
   PubMed Web of Science ®Google Scholar
• Rombach I, Gray AM, Jenkinson C, et al. Multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level. BMC Med Res Methodol. 2018;18(1):87–87.
   PubMedGoogle Scholar
• Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci. 2007;8(3):206–213.
   PubMed Web of Science ®Google Scholar
• Hair JF, Black WC, Babin BJ, et al. Chapter 2: examining your data. Multivariate data analysis (revised). 7th ed. Prentice Hall: Pearson Education Limited; 2014. p. 31–88.
   Google Scholar
• Kleinbaum DG, Kupper LL, Nizam A, et al. Selecting the best equation regression. Applied regression analysis and other multivariable methods. Vol. 5. Australia: Cengage Learning; 2014. p. 438–480.
   Google Scholar
• Gagnon C, Petitclerc E, Kierkegaard M, et al. A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1. J Neurol. 2018;265(7):1698–1705.
   PubMed Web of Science ®Google Scholar
• Kalkman JS, Schillings ML, Zwarts MJ, et al. The development of a model of fatigue in neuromuscular disorders: a longitudinal study. J Psychosom Res. 2007;62(5):571–579.
   PubMed Web of Science ®Google Scholar
• Morley D, Dummett S, Kelly L, et al. Predictors of activity and participation across neurodegenerative conditions: a comparison of people with motor neurone disease, multiple sclerosis and Parkinson's disease. BMC Neurol. 2018;18(1):19.
   PubMed Web of Science ®Google Scholar
• Van Heugten C, Meuleman S, Hellebrekers D, et al. Participation and the role of neuropsychological functioning in myotonic dystrophy type 1. J Neuromuscul Dis. 2018;5(2):205–214.
   PubMedGoogle Scholar
• Peric S, Stojanovic VR, Basta I, et al. Influence of multisystemic affection on health-related quality of life in patients with myotonic dystrophy type 1. Clin Neurol Neurosurg. 2013;115(3):270–275.
   PubMed Web of Science ®Google Scholar
• Rakocevic-Stojanovic V, Peric S, Madzarevic R, et al. Significant impact of behavioral and cognitive impairment on quality of life in patients with myotonic dystrophy type 1. Clin Neurol Neurosurg. 2014;126:76–81.
   PubMed Web of Science ®Google Scholar
• Landfeldt E, Nikolenko N, Jimenez-Moreno C, et al. Disease burden of myotonic dystrophy type 1. J Neurol. 2019;266(4):998–1006.
   PubMed Web of Science ®Google Scholar
• Laberge L, Gallais B, Auclair J, et al. Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1. J Neurol. 2020;267(2):461–468.
   PubMed Web of Science ®Google Scholar
• Petty RKH, Eugenicos MP, Hamilton MJ, et al. The prevalence of faecal incontinence in myotonic dystrophy type 1. Neuromuscul Disord. 2019;29(7):562–566.
   PubMed Web of Science ®Google Scholar
• de Die-Smulders CE, Howeler CJ, Thijs C, et al. Age and causes of death in adult-onset myotonic dystrophy. Brain. 1998;121(8):1557–1563.
   PubMedGoogle Scholar
• Mathieu J, Allard P, Potvin L, et al. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology. 1999;52(8):1658–1662.
   PubMed Web of Science ®Google Scholar
• Yam A, Marsiske M. Cognitive longitudinal predictors of older adults' self-reported IADL function. J Aging Health. 2013;25(8 Suppl.):163S–185S.
   PubMed Web of Science ®Google Scholar
• Jean S, Richer L, Laberge L, et al. Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1). Orphanet J Rare Dis. 2014;9(1):186.
   PubMedGoogle Scholar
• Gagnon C, Heatwole C, Hebert LJ, et al. Report of the third outcome measures in myotonic dystrophy type 1 (OMMYD-3) international workshop Paris, France, June 8, 2015. J Neuromuscul Dis. 2018;5(4):523–537.
   PubMedGoogle Scholar
• Gagnon C, Meola G, Hébert LJ, et al. Report of the second outcome measures in myotonic dystrophy type 1 (OMMYD-2) international workshop San Sebastian, Spain, October 16, 2013. Neuromuscul Disord. 2015;25(7):603–616.
   PubMed Web of Science ®Google Scholar
• Gagnon C, Meola G, Hebert LJ, et al. Report of the first outcome measures in myotonic dystrophy type 1 (OMMYD-1) international workshop: clearwater, Florida, November 30, 2011. Neuromuscul Disord. 2013;23(12):1056–1068.
   PubMed Web of Science ®Google Scholar
• Roussel MP, Morin M, Gagnon C, et al. What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review BMC Musculoskelet Disord. 2019;20(1):101.
   PubMedGoogle Scholar
• Roussel MP, Hébert LJ, Duchesne E. Strength-training effectively alleviates skeletal muscle impairments in myotonic dystrophy type 1. Neuromuscul Disord. 2020;30(4):283–293.
   PubMed Web of Science ®Google Scholar
• Okkersen K, Jimenez-Moreno C, Wenninger S, et al. Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial. Lancet Neurol. 2018;17(8):671–680.
   PubMed Web of Science ®Google Scholar
• LaDonna KA, Venance SL. Picturing the experience of living with myotonic dystrophy (DM1): a qualitative exploration using photovoice. J Neurosci Nurs. 2015;47(5):285–295.
   PubMed Web of Science ®Google Scholar
• Douglas H, Georgiou A, Westbrook J. Social participation as an indicator of successful aging: an overview of concepts and their associations with health. Aust Health Rev. 2017;41(4):455–462.
   PubMed Web of Science ®Google Scholar
• Veenstra G, Vanzella-Yang A. Family income and self-rated health in Canada: using fixed effects models to control for unobserved confounders and investigate causal temporality. Soc Sci Med. 2020;250:112884.
   PubMed Web of Science ®Google Scholar
• Seijas VA, Lugo LH, Cano B, et al. Understanding community-based rehabilitation and the role of physical and rehabilitation medicine. Eur J Phys Rehabil Med. 2018;54(1):90–99.
   PubMed Web of Science ®Google Scholar
• LaDonna KA, Watling CJ, Ray SL, et al. Evolving motivations: patients' and caregivers' perceptions about seeking myotonic dystrophy (DM1) and Huntington's Disease Care. Qual Health Res. 2017;27(11):1727–1737.
   PubMed Web of Science ®Google Scholar
• Cumming SA, Jimenez-Moreno C, Okkersen K, et al. Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort. Neurology. 2019;93(10):e995–e1009.
   PubMed Web of Science ®Google Scholar
• Park D, Lee S-H, Shin J-H, et al. Lower limb muscle magnetic resonance imaging in myotonic dystrophy type 1 correlates with the six-minute walk test and CTG repeats. Neuromuscul Disord. 2018;28(1):29–37.
   PubMed Web of Science ®Google Scholar
• Rossi S, Della Marca G, Ricci M, et al. Prevalence and predictor factors of respiratory impairment in a large cohort of patients with myotonic dystrophy type 1 (DM1): a retrospective, cross sectional study. J Neurol Sci. 2019;399:118–124.
   PubMed Web of Science ®Google Scholar
• Hogrel JY, Ollivier G, Ledoux I, et al. Relationships between grip strength, myotonia, and CTG expansion in myotonic dystrophy type 1. Ann Clin Transl Neurol. 2017;4(12):921–925.
   PubMed Web of Science ®Google Scholar
• Liu JY. The severity and associated factors of participation restriction among community-dwelling frail older people: an application of the International Classification of Functioning, Disability and Health (WHO-ICF). BMC Geriatr. 2017;17(1):43.
   PubMed Web of Science ®Google Scholar
• Kim DH, Newman AB, Lipsitz LA. Prediction of severe, persistent activity-of-daily-living disability in older adults. Am J Epidemiol. 2013;178(7):1085–1093.
   PubMed Web of Science ®Google Scholar
• Levasseur M, Desrosiers J, Whiteneck G. Accomplishment level and satisfaction with social participation of older adults: association with quality of life and best correlates. Qual Life Res. 2010;19(5):665–675.
   PubMed Web of Science ®Google Scholar
• Boström K, Ahlström G. Living with a chronic deteriorating disease: the trajectory with muscular dystrophy over ten years. Disabil Rehabil. 2004;26(23):1388–1398.
   PubMed Web of Science ®Google Scholar
• Cup EH, Kinébanian A, Satink T, et al. Living with myotonic dystrophy; what can be learned from couples? A qualitative study. BMC Neurol. 2011;11(1):86.
   PubMedGoogle Scholar
• LaDonna KA, Ghavanini AA, Venance SL. Truths and misinformation: a qualitative exploration of myotonic dystrophy. Can J Neurol Sci. 2015;42(3):187–194.
   PubMed Web of Science ®Google Scholar
• Gallais B, Montreuil M, Gargiulo M, et al. Prevalence and correlates of apathy in myotonic dystrophy type 1. BMC Neurol. 2015;15(1):148–148.
   PubMedGoogle Scholar
• Kierkegaard M, Petitclerc E, Hebert LJ, et al. Responsiveness of performance-based outcome measures for mobility, balance, muscle strength and manual dexterity in adults with myotonic dystrophy type 1. J Rehabil Med. 2018;50(3):269–277.
   PubMed Web of Science ®Google Scholar
• Baldanzi S, Bevilacqua F, Lorio R, et al. Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study. Orphanet J Rare Dis. 2016;11(1):1–11.
   PubMedGoogle Scholar